- Featured News /
European Patient Innovation Summit publishes a position paper on Digital Health from a Patient Perspective with recommendations on digital health.
- Featured News /
On April 9, 2019 Alcon becomes a separately traded company. Novartis and Alcon are now positioned to capitalize on significant growth opportunities and focus resources on their respective businesses and strategic priorities.
- Featured News /
Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.
- Featured News /Novartis CEO Vas Narasimhan announced the company’s fourth quarter and 2018 full year results.
- Statement /
Form 483 posting by US Food and Drug Administration (FDA) – Novartis statement
- Featured News /
Over 1,800 delegates came together at the annual Co-Creating Impact Summit to explore how understanding ‘impact’ is a crucial step in ensuring business makes a positive contribution to the world.
- Statement /
- Featured News /
Results of the Sickle Cell World Assessment Survey (SWAY) highlight the impact this debilitating disease has on patients and their families.
- Featured News /
Patient community representatives call for improved digital health literacy, standardised digital platforms, and co-creation of digital solutions.
- Featured News /
Novartis maintained its position in the 2021 Access to Medicine Index, leading in its approach to product delivery, while performing strongly across all other areas of the Index.
Pagination
- ‹ Previous page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- › Next page